Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
Clinical trial NCT03194776 · COMPLETED
Trial details
- NCT number
- NCT03194776
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2018-09-07
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.